Monopar Announces Positive Preclinical Therapeutic Isotope Data for its MNPR-101 Radiopharma Program
WILMETTE, Ill., March 05, 2024 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (MNPR), a clinical-stage biopharmaceutical company focused on developing innovative treatments for cancer patients, today ...
Bruce Power's Chief Operating Officer James Scongack is also Chairman of the Canadian Nuclear Isotope Council and, as he explains, the country is aiming to grow its leadership role in nuclear medicine ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results